Showing results (851-860 of 4,380) with videos related to
Sort By:
Pageof 438
ACS Medicinal Chemistry Letters|August 4, 2025
One Tracer, Dual Platforms: Unlocking Versatility of Fluorescent Probes in TR-FRET and NanoBRET Target Engagement AssaysErika Y Monroy, Xin Yu, Dong Lu, et al.ACS Medicinal Chemistry Letters|July 16, 2025
Novel Indole Derivatives as Serotonergic Psychedelic Agents for Treating Psychosis, Mental Illness, and CNS DisordersRam W SabnisACS Medicinal Chemistry Letters|July 16, 2025
Homogeneous Dual-Payload Antibody-Drug Conjugates Produced by Combined Distinct Conjugation StrategiesTomohiro Watanabe, Yusuke Iwai, Jason T Stofleth, et al.ACS Medicinal Chemistry Letters|July 16, 2025
Discovery of a Novel sp3‑Rich M1 Positive Allosteric Modulators (PAMs) Chemotype via Scaffold HoppingJoseph D Bungard, Paul Spearing, Yu Nishio, et al.ACS Medicinal Chemistry Letters|July 16, 2025
Structural Optimization of Antifungal Peptoids targeting Candida albicansMary N Tran, Kevin L BickerACS Medicinal Chemistry Letters|July 16, 2025
Discovery of Potent FGFR2/3 Inhibitors to Overcome Mutation Resistance and Treat AchondroplasiaDonglin Fu, Tian Han, Zimo Yang, et al.ACS Medicinal Chemistry Letters|July 16, 2025
Design, Synthesis, and Biological Evaluation of Novel Hydroxyamidine Derivatives as Indoleamine 2,3-Dioxygenase 1 InhibitorsXiaodan Qiu, Yitong Liu, Xia Zhou, et al.ACS Medicinal Chemistry Letters|July 16, 2025
Design, Synthesis, and Biological Evaluation of Ferrocenyl-Cyclo-(Gly‑l‑Pro) Hybrids Sensitizing Multidrug-Resistant Cancer Cells to Anticancer AgentsAndrzej Błauż, Karolina Rózga, Małgorzata Nosek, et al.ACS Medicinal Chemistry Letters|July 16, 2025
Novel Heterocyclic 5H‑Dibenzo[b,f]azepine Derivatives as Selective HDAC6 Inhibitors for Treatment of Charcot Marie Tooth DiseaseSteven H LiangACS Medicinal Chemistry Letters|July 16, 2025
Novel Tricyclic Psychedelic Psychoplastogens as 5‑HT2C Agonists for Treating Neurological DiseasesRam W SabnisPageof 438